(Press-News.org) BOSTON (April 26, 2011) —Human papillomavirus (HPV) causes cervical cancer, the second most common cause of cancer death for women, and is a common cause of anogenital and some head and neck cancers. Thanks to research being done at Tufts University School of Medicine, patients infected with cancer-causing HPV may someday have an alternative to surgical and harsh chemical treatments. In a study funded by the National Institutes of Health and published online in advance of print in The FASEB Journal, the researchers report on the development of a protein-based inhibitor that could provide a topical treatment for HPV.
"Currently, there is no cure for HPV, and the available treatment options involve destroying the affected tissue. We have developed a protein inhibitor that blocks HPV protein expression in cell culture, a first step toward a topically-applied treatment for this cancer-causing virus," said senior author James Baleja, PhD, associate professor of biochemistry at Tufts University School of Medicine (TUSM) and member of the biochemistry program faculty at the Sackler School of Graduate Biomedical Sciences at Tufts.
"Vaccines are helping to lower the incidence of HPV, but vaccines will not help the millions of women and men who currently have an infection, especially those who have high-risk and persistent infections. Social and economic challenges make widespread administration of a vaccine difficult, particularly in developing countries. A topical treatment for HPV could provide an economical option," he continued.
HPV affects approximately 20 million people in the United States, making it the most common sexually transmitted infection. There are more than 100 types of HPV of which more than 40 are sexually transmitted. These include two high-risk types, HPV-16 and HPV-18, which cause the majority of cervical and anogenital cancers, and some portion of head and neck cancers, particularly oral cavity and oropharynx cancers. Cervical cancer is diagnosed in nearly 500,000 women each year, killing 250,000 annually. In the United States, it was estimated that 12,000 women in 2010 would be diagnosed with cervical cancer, while 10,100 women and men in the United States get vulvar, vaginal, penile or anal cancers each year. In addition, some portion of the head and neck cancers in the United States (11,300 men and women each year) is attributable to HPV. Other types of HPV, or low-risk HPV, can cause genital warts or are infections that clear on their own.
In their efforts to inhibit HPV, Baleja and his team zeroed in on the viral protein E2, which controls viral activities including DNA replication and the activation of cancer-causing genes. Using structure-guided design, the team developed a protein called E2R that prevents E2 from functioning normally. When the researchers applied E2R to a cell model of HPV biology, viral gene transcription was halted. Because HPV infects epithelial cells, the outermost layer of the skin and the mucous membranes, protein inhibitors such as E2R could be applied in a topical form.
Baleja and colleagues used biophysical tools including circular dichroism spectroscopy and x-ray crystallography to test the structure and stability of different inhibitors. The most stable inhibitor was then tested in mammalian cells and was found to inhibit the E2 protein of HPV-16, the high-risk strain that is most commonly associated with cancers. The data in this study suggest that the inhibitor may also be effective against another high-risk virus, HPV-18, as well as a low-risk virus, HPV-6a, which causes warts.
###
Additional authors on the paper are first author Kakoli Bose, PhD, formerly a postdoctoral fellow in the Baleja laboratory at TUSM and now with the Advanced Centre for Treatment, Research and Education in Cancer at the Tata Memorial Center in India; Gretchen Meinke, PhD, senior research associate in the Bohm Laboratory at TUSM, and Andrew Bohm, associate professor in the Department of Biochemistry at TUSM and member of the biochemistry program faculty at the Sackler School of Graduate Biomedical Sciences.
This research was funded by the National Cancer Institute, part of the National Institutes of Health, and by the Lifespan/Tufts/Brown Center for AIDS Research (CFAR), a joint research effort between Tufts and Brown Universities and their affiliated hospitals and centers. CFAR is funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
Bose K, Meinke G, Bohm A, and Baleja J. The FASEB Journal. "Design and characterization of an enhanced repressor of human papillomavirus E2 protein." Published online April 11, 2011. DOI 10.1096/fj.10-176461
About Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences
Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts University are international leaders in innovative medical education and advanced research. The School of Medicine and the Sackler School are renowned for excellence in education in general medicine, biomedical sciences, special combined degree programs in business, health management, public health, bioengineering and international relations, as well as basic and clinical research at the cellular and molecular level. Ranked among the top in the nation, the School of Medicine is affiliated with six major teaching hospitals and more than 30 health care facilities. Tufts University School of Medicine and the Sackler School undertake research that is consistently rated among the highest in the nation for its effect on the advancement of medical science.
Protein inhibitor may bring a topical treatment for HPV
2011-04-26
ELSE PRESS RELEASES FROM THIS DATE:
Water molecules characterize the structure of DNA genetic material
2011-04-26
Water molecules surround the genetic material DNA in a very specific way. Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have discovered that, on the one hand, the texture of this hydration shell depends on the water content and, on the other hand, actually influences the structure of the genetic substance itself. These findings are not only important in understanding the biological function of DNA; they could also be used for the construction of new DNA-based materials.
The DNA's double helix never occurs in isolation; instead, its entire surface is ...
Study examines folic acid absorption rates from softgel capsule and standard tablet
2011-04-26
NORTHRIDGE, CA (April 26, 2011) — Folic acid, an essential vitamin formulated to be part of a multivitamin + DHA liquid softgel capsule, is absorbed and available within the body in amounts similar to folic acid formulated for solid tablets, according to a study presented in a late breaking session at the Experimental Biology (EB) 2011 annual meeting. Different formulations, fillers and coatings of vitamin products may affect the degree or rate at which the product dissolves and releases its contents, which can alter the vitamin's absorption into the body and its bioavailability, ...
Motor protein may offer promise in ovarian cancer treatment
2011-04-26
A motor regulatory protein can block human ovarian tumor growth, leading to eventual cancer cell death and possible new therapies to treat the disease, according to Penn State College of Medicine researchers.
Among U.S. women, an estimated 21,880 new cases and 13,850 deaths occurred in 2010 from epithelial ovarian cancer, one of the most common forms of ovarian cancer and the most lethal gynecologic cancer in women.
Previously, Kathleen M. Mulder, Ph.D., professor, biochemistry and molecular biology, along with members of her laboratory, learned that km23-1 -- a protein ...
Chernobyl's radioactivity reduced the populations of birds of orange plumage
2011-04-26
On April 26, 1986, history's greatest nuclear accident took place northwest of the Ukrainian city of Chernobyl. Despite the scale of the disaster, 25 years later, we still do not know its real effects. An international team of investigators has shown for the first time that the colour of birds' plumage may make them more vulnerable to radioactivity.
Radiation causes oxidative stress, damages biological molecules and may have "important" negative effects on organisms in relatively high doses, like those found in certain zones close to Chernobyl.
"In the case of the ...
NRL scientists focus on light ions for fast ignition of fusion fuels
2011-04-26
(WASHINGTON) -- Scientists at the Naval Research Laboratory Plasma Physics Division demonstrate significant progress in the efficiency and cost effectiveness of light ions in the fast ignition of fusion targets. Light ions such as lithium or carbon are easier to produce technologically and the ion beam properties can be manipulated and tailored best to suit the necessary requirements for fast ignition.
The fast ignition concept has been conceived as an alternative to other approaches for nuclear fusion energy. In the fast ignitor scenario a high-energy particle beam, ...
Erickson Law and The Surrogacy Lawyer Radio Show Offers Free Banner Advertising and Awareness to Infertility Non-Profits In Honor of National Infertility Awareness Week, April 24-30
2011-04-26
In honor of National Infertility Awareness Week, "The Surrogacy Lawyer" Theresa M. Erickson, managing partner of Erickson Law and host of The Surrogacy Lawyer Radio Show on Voice America, announced her firm is offering free banner advertising on its radio show Website to the many infertility nonprofit organizations that offer support, advocacy and education to infertility patients.
National Infertility Awareness Week (NIAW) is being held this year from April 24-30 and is the only federally recognized week promoting education and awareness about the disease ...
Topical treatment may prevent melanoma
2011-04-26
While incidents of melanoma continue to increase despite the use of sunscreen and skin screenings, a topical compound called ISC-4 may prevent melanoma lesion formation, according to Penn State College of Medicine researchers.
"The steady increase in melanoma incidence suggests that additional preventive approaches are needed to complement these existing strategies," said Gavin Robertson, Ph.D., professor of pharmacology, pathology, dermatology and surgery, and director of Penn State Hershey Melanoma Center.
Researchers targeted the protein Akt3, which plays a central ...
New discovery could 'green up' hundreds of everyday products
2011-04-26
WASHINGTON, April 26, 2011 — The American Chemical Society (ACS) today released a new episode in its award-winning "Global Challenges/Chemistry Solutions" podcast series showcasing a discovery that could mean greener and more environmentally friendly production of a key ingredient used to make everything from paint to diapers.
The podcast and accompanying website focus on a new way to make acrylic acid, a key industrial material that's usually produced from pricey and increasingly scarce petroleum. It involves development of a new catalyst that permits production of ...
A potential novel drug-target for colorectal cancer treatment comes from the brain
2011-04-26
Porto Alegre, Brazil- Tumor progression is usually ensured by more than one proliferative mechanism. When one of these is shut down by a specifically targeted drug, other mechanisms may emerge. While these events may lead to treatment failure, they may also become an opportunity for researchers to identify novel targets to be further explored. In a paper recently published in the journal Oncology ("BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer," Vol. 79, pages 430-439, 2011; DOI: 10.1159/000326564) Roesler and colleagues ...
Brain imaging demonstrates that former smokers have greater willpower
2011-04-26
London - 26 April, 2011 – A study, completed by researchers from Trinity College and the Research Institute for a Tobacco Free Society, Dublin, Ireland, compares former smokers to current smokers, and obtains insight into how to quit smoking might be discovered by studying the brains of those who have successfully managed to do so.
Functional MRI images were obtained while current smokers, former smokers and never smokers performed tasks designed to assess specific cognitive skills that were reasoned to be important for smoking abstinence. These included a response ...